Abstraet: The intent of this critica! assessment was to review key areas of tbe clinical and technical work flow in a critica! care environment as it pertains to the variations that exist between 2 cartridge-based blood gas systerns, namely, the Siemens RAPIDPoint 405 and tbe IL GEM4000. Cartridge-based blood gas systems on tbe surface would seem to completely remove tbe need for maintenance or technical/ clinical intervention; however, careful clinical assessment high1ights a number of áreas tbat require consideration. On replacement of cartridges, considerable \'aIi2:IiOnS exist between manufacturers before tbe system is fully opernIi.oozl of quality and reliability of results is manul'i!!:. the remote IT management and control have led to marked improvements in patient care because of the reliability of the systems-allowing clinicians more time to treat their patients and the delivery of laboratory-accurate patient results from a point-of-care system. During the last 10 years, cartridge-basedblood gas analyzers developed for fue point-of-care environrnent have evolved to rninirnize fue number of components into as few consumables as required, thereby ensuring that fue levels of maintenance required are reduced. In addition, the procedures required to operate and manage the instrurnents have been considerably simplified so that nonlaboratory personnel can perform these tasks if required, thereby reducing the time burden of laboratories and reducing institutional overall costs. Different variations on end-user evaluations of competencies required to operate and maintain cartridge-based systems, with the underpinning reliability of the system, are important factors that require careful consideration before implementation of a cartridge-based blood gas system..
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Tbis objective of this study was to determine the work flow implications involved with fue implementation of the Siemens Healthcare Diagnostics RAPIDPoint 405 system (Norwood, Mass) and Instrumentation Laboratory GEM4000 (Lexington, Mass) point-of-care testing systems into routine clinical use. Within this assessment of cartridge-based blood gas systems, it was considered appropriate to determine all aspects of technical and clinical intervention that is required to ensure accurate and reliable functionality of the systems at all times. It is an important consideration when consolidating or standardizing technologies to be fully aware of the total extent of the work flow required to manage the cartridge-based blood gas instrumentation.
METHODS
This study sought to investigate all technical and clinical aspects required to operate and manage fue Siemens RAPIDPoint 405 and IL GEM4000 instruments and the respective times associated with completing these steps.
The study was conducted during a 90-day periodo Two Siemens RAPIDPoint 405 and 2 IL GEM4000 systems were used throughout fue duration of fue study to eliminate any extraneous factors that may skew fue study results.
For a direct comparison between instrurnents, analyzers were located side-by-side, and identical samples were analyzed on both systerns to ensure that each system was exposed to identical factors. Within this study, all aspects required to maintain fue operational functionality of the respective instruments were recorded, and fue time required to perform each task was recorded.
The following work flow evaluation processes were investigated, .and the time required undertaking each process was recorded. A minimum of 100 patient samples per instrurnent were analyzed to ensure a meaningful representation of the work flow dynamics of each system. 
RESULTS
The mean time for cartridge initialization varied consíd-erably between manufacturers' with the RAPIDPoint 405 at 25 minutes and the GEM4000 at 45 minutes ( Fig. 1 and Table 1 ). In addition, the RAPIDPoint 405 required the installation of a wash/waste and AQC cartridge, which added, on average, 6 minutes to the installation. However, even with the additional cartridges, the total installation time required for cartridge installation on the RAPIDPoint 405 was 31 minutes compared to 45 minutes for GEM4000. Thereby, the RAPIDPoint 405 system is available to report patient results 31 % faster than the GEM4000 after cartridge installation.
To verify instrument functionality, after cartridge installation has been completed, both systems require specific procedures to be performed before running patient samples. For the RAPIDPoint 405 system, AQC must be run. For the GEM4000, the calibration verification procedure (CVP) is required. The CVP process, on average, took 15 minutes compared to the AQC with RAPIDPoint 405 at approximately 5 minutes (Table 2 and Fig. 2 ). The total time required to ensure complete functionality ofthe GEM4000 is approximately 60 minutes versus the shorter time requirement of approximately 36 minutes on the RAPIDPoint 405. It is important to point out that, with the intelligent quality management application on the GEM4000, no further external quality control materials are required to ensure functionality of the system throughout the use life of the cartridge. The RAPIDPoint 405, on the other hand, requires the running of AQC (externa! quality control) on a daily basis-a process that takes approximately 5 minutes to complete. However, this step is fully automated and requires no clinical intervention by hospital personnel. It is important to note that with the Siemens RAPIDPoint 405, when all consumables have been installed, all additional analytical procedures to ensure functionality of the instrument can be controlled remotely by an integrated IT solution. However, with the GEM4000, a subsequent visit to the Table 3 ). The availability of !he RAPIDPoint 40 ID anaIyze the next -in _ seconds is -6 times -seconds.. Over time. tbe total <::E~ic2.! s:::::;pIíOg_ beween me introductions of consamples was fonnd to be 110 seconds on the RAPIDPoint 40S and 200 seconds on the GEM4000-verifying that the RAPIDPoint 405 system is most likely to be available for the next sample analysis at nearly double the time than that ofthe GEM4000.
Within this work flow model, to obtain a better assessment of the actual analytical throughput of each system, both the minimum and maximum patient sample throughputs were detennined for each (Table 4 and throughput with the Siemens RAPIDPoint 405 was 37 versus 19 samples per hour with the GEM4000-nearly 2 times more samples can be analyzed on the RAPIDPoint 405 system under optimal conditions. The same holds true under less-than-optimal conditions, whereby the throughput of the RAPIDPoint 405 system is approximately 80% higher than the GEM4000 (29 vs 16 samples per hour). It is evident from this study that there is a marked variation in the analytical throughput of each system, and this should be taken into consideration when evaluating cartridge-based blood gas systems, especially those that may be implemented in high-volume point-of-care locátions.
DISCUSSION
Cartridge-based blood gas systems, on the surface, would seem to completely remove the need for hands-on maintenance or technical/clinical intervention. However, a thorough clinical assessment highlights a number of areas that may require (5) 105 (12) 200 (17) 70 (7) 40 (7) 110 (14) consideration before implementing a cartridge-based blood gas system in an institution. Within this study, considerable variability was documented on the time to first patient analysis after installation of the cartridges with Siemens RAPIDPoint 405 requiring 36 minutes on average and the IL GEM4000 requiring nearly 60 minutes. Regarding the RAPIDPoint 405 system, as the measurement cartridges were replaced on a 28-day cycle, this necessitates 13 replacements per year, equating to 312 minutes per year or 5.2 hours per instrument. Regarding the GEM4000, the CVP, required for the activation of intelligent quali~man-agement software, cannot be performed remotely and requrres an operator to remain with the instrument throughout the CVP process or to periodically check on the analyzer to verify the acceptable completion ofthe CVP process. This is in contrast to the RAPIDPoint 405 system, where once the cartridges have been installed on the analyzer, it is a true walk away system as the' quality control process is performed automatically .~d do es not require any intervention by an operator. In addition, the availability of the RAPIDPoint 405 for sample analysis may be monitored remotely to allow for personnel to attend to other activities because they do not have to remain with or return to the instrument. In effect, the operator only has to remain with the RAPIDPoint 405 instrument for approximately 5 minutes (the time required to install the measurement cartridge). In a work flow model, there is considerable variation in staff time required to ensure blood gas analyzer functionality even with the cartridge-based systems, which may impact operationally on staff personnel requirements, manpower hours, and overall cost to the institution, To assess the affect on work flow on aninstitution with the implementation of cartridge-based blood gas systems, both the RAPIDPoint 405 and the GEM4000 systems were evaluated for sampling time, time to next sample, and analytical throughput within this work flow assessment. Marked variations between manufacturers were apparent for actual patient analysis timeRAPIDPoint 405 at 70 seconds to perform sample analysis compared to 95 seconds with the GEM4000. Sample to consecutive sample time was a shorter 110 seconds with RAPIDPoint 405 compared to 200 seconds with GEM4000. Finally,ã nalytical throughput, RAPIDPoint 405 demonstrated a maximum t1rroughput of37 samples per hour compared to GEM4000 at only 19 samples per hour-nearly double. In the point-of-care environment, sample analytical throughput has a significant impact on patient-result-nn:naround~es and the importance of obtaining a patient result quickly to administer appropriate therapeutic actions.
This assessment was conducted with the intent to review key areas of work flow as it pertains to the variations uncovered that exist between 2 cartridge-based blood gas systems, the RAPIDPoint 4ü5 and the GEM4000. On the basis ofthe findings in this assessment, it is important to point out that those key areas such as sampling time, the time to next sample, and the system anaIytical throughput should be taken into consideration in ad~i~?n to a complete understanding of the true walk-away capabilities when implementing a cartridge-based blood gas system.
